A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
Financial Summary
| Share Statistics | GRRMY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,094.1 | $1,790.4 | 46% |
|
| Shares Out (Mil) | 40.1 | 94.8 | 43% |
|
| Institutional Ownership | 46.9% | 90.0% | 21% |
|
| Float (Mil) | 32.0 | 69.9 | 38% |
|
| Beta | 0.48 | 1.20 | 27% |
|
| Avg Daily Volume (000s) | 1 | 814 | 4% |
|
| Price Change (52-week) |
na | 80.2% | na |
|
| Growth | GRRMY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 9.7% | 7.8% | 57% |
|
| Net Income (5yr) | (40.7%) | (13.7%) | 9% |
|
| EPS (5yr) | (39.0%) | 0.7% | 6 |
|
| Dividends (5yr) | (14.9%) | 0.0% | 0% |
|
| Cash Flow (5yr) | (27.3%) | (15.0%) | 22% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | GRRMY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,691 | $785 | 65% |
|
| Net Income (TTM) (Mil) | ($371) | ($14) | 4% |
|
| EPS (TTM) | ($10.753) | ($0.200) | 4% |
|
| Operating Cash Flow (TTM) (Mil) | $243 | $53 | 62% |
|
| Net Cash Flow (TTM) (Mil) | ($8) | ($4) | 32% |
|
| Long-Term Debt (Q1) (Mil) | $1,855 | $270 | 73% |
|
| Enterprise Value (Q1) (Mil) | $3,617 | $2,444 | 57% |
|
| Valuation | GRRMY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.92 | na |
|
| P/E | na | 43.7 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 5.3 | na |
|
| Ratios | GRRMY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 23.6% | 47.6% | 26% |
|
| Net Margin | (13.8%) | (2.9%) | 19% |
|
| ROA | (8.1%) | (2.8%) | 27% |
|
| ROE | (26.4%) | (4.5%) | 21% |
|
| Liabilities to Assets | 75.4% | 43.0% | 71% |
|
| F-Score | na | 5 | na |
|
Gerresheimer AG did not pass any screens on 7/31/2026.
